Related Experiment Video
Updated: Jun 28, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Presentation and Management of Acute Mania in Fanconi-Bickel Syndrome, A Metabolic Genetic Disorder
Allen P F Chen1, Geoffrey Russell2, Amnie Ashour3
1Medical Scientist Training Program, Renaissance School of Medicine, Stony Brook, NY, USA.
Abstract:
Fanconi-Bickel syndrome (FBS) is a rare metabolic disorder caused by decreased glucose transporter 2 (GLUT2) function due to several known mutations in the SLC2A2 gene. As of 2020, 144 cases of FBS have been described in the literature. Metabolic and somatic sequelae include dysglycemia and accumulation of glycogen in the kidney and liver. However, there are no descriptions in the literature of possible neuropsychiatric manifestations of FBS. This case report is to our knowledge the first in this regard, describing a patient with FBS who was admitted to our psychiatric inpatient unit while experiencing acute mania. We conceptualize the case as a novel psychiatric presentation of acute mania in FBS, which may inform our understanding of bipolar disorder pathophysiology because of the hypothesized functional changes in neural pathways involving the paraventricular thalamus induced by decreased GLUT2 activity in FBS.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Acute Pancreatitis II: Clinical Manifestations and Management
Bipolar Disorder
Hypoglycemia and Glucagon
Electroconvulsive Therapy
Binge Eating Disorders

